KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Citrobacter freundii (GN346 + cephalosporin-resistant)

• Citrobacter freundii
• Citrobacter freundii (3757 + β-lactamase positive)
• Citrobacter freundii (44032)
• Citrobacter freundii (47051)
• Citrobacter freundii (amp(C)-negative)
• Citrobacter freundii (amp(C)-positive)
• Citrobacter freundii (ampicillin-resistant + cefazolin-resistant)
• Citrobacter freundii (ATCC 8090 + CAMHB + pH 5.8)
• Citrobacter freundii (ATCC 8090 + CAMHB + pH 7.2)
• Citrobacter freundii (ATCC 8090)
• Citrobacter freundii (Basal amp(C))
• Citrobacter freundii (C2-con)
• Citrobacter freundii (cefpirome-resistant)
• Citrobacter freundii (ceftazidime-resistant)
• Citrobacter freundii (ceftazidime-susceptibl)
• Citrobacter freundii (ceftazidime-susceptible)
• Citrobacter freundii (CT76)
• Citrobacter freundii (ESBL)
• Citrobacter freundii (Europe + ceftazidime-resistant)
• Citrobacter freundii (Europe)
• Citrobacter freundii (GN 7391)
• Citrobacter freundii (GN346 + cephalosporin-resistant)
• Citrobacter freundii (GN7391 + amp(C))
• Citrobacter freundii (GN7391 + cephalosporin-resistant)
• Citrobacter freundii (Hyperproducing amp(C))
• Citrobacter freundii (IFO 12681)
• Citrobacter freundii (IID 976)
• Citrobacter freundii (Inducible amp(C))
• Citrobacter freundii (MTCC 1658)
• Citrobacter freundii (NCIM 2488)
• Citrobacter freundii (NIH 10018-68)
• Citrobacter freundii (North America + ceftazidime-resistant)
• Citrobacter freundii (North America)
• Citrobacter freundii (TN474)
• Citrobacter freundii (TP)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8